Hatem Abusriwil
Hamad Medical Corporation(QA)
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, COVID-19 Clinical Research Studies, Asthma and respiratory diseases, Atrial Fibrillation Management and Outcomes, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Validation of assays for inflammatory mediators in exhaled breath condensate(2008)42 cited
- → Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report(2020)37 cited
- → Alpha-1-antitrypsin replacement therapy: current status(2006)36 cited
- → Switch to oral antibiotics in Gram-negative bacteraemia: a randomized, open-label, clinical trial(2023)26 cited
- → Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs(2022)10 cited
- → Infective Exacerbation ofPasteurella multocida(2016)6 cited
- → The Interaction of Host and Pathogen Factors in Chronic Obstructive Pulmonary Disease Exacerbations and Their Role in Tissue Damage(2007)6 cited
- → Bacterial Load and Exacerbations of COPD(2008)5 cited
- → Spontaneous hemothorax caused by rivaroxaban treatment for pulmonary embolism: A case report(2023)3 cited
- → (2009)1 cited